Literature DB >> 7560969

Epidemiology of candidiasis.

M A Pfaller1.   

Abstract

The increase in infections due to Candida over the past decade is significant. This is particularly true for hospitalized patients where the rate of blood-stream infection due to Candida spp. has increased by almost 500% over the decade of the 1980s. This increase is accompanied by a significant excess mortality and a prolonged length of stay in the hospital. This trend continues into the 1990s where in the US Candida spp. remains the fourth most common blood-stream pathogen, accounting for 8% of all hospital-acquired blood-stream infections. Notably, more than one-third of candidal blood-stream infections are caused by species other than C. albicans. The majority of these infections arise from an endogenous focus of colonization; however, the documentation of nosocomial transmission or 'cross-infection' and the recognition of resistance to antifungal agents pose new and significant problems. Recent studies indicate that Candida may be isolated from the hands of 15-54% of health care workers in the intensive care unit setting and that the strain of Candida carried on the hands may be shared by infected patients. These studies are facilitated by molecular typing and careful epidemiological investigation and suggest that cross-infection is an important and preventable feature of candidal blood-stream infection. Both endogenous and exogenous sources of infection are now well-documented and such information should help direct measures to prevent infections in high risk individuals.

Entities:  

Mesh:

Year:  1995        PMID: 7560969     DOI: 10.1016/0195-6701(95)90036-5

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  33 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  In vitro susceptibilities of clinical yeast isolates to the new antifungal eberconazole compared with their susceptibilities to clotrimazole and ketoconazole.

Authors:  J M Torres-Rodríguez; R Mendez; O López-Jodra; Y Morera; M Espasa; T Jimenez; C Lagunas
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Detection of Candida dubliniensis in Venezuela.

Authors:  Claudia Hartung de Capriles; Sofía Mata-Essayag; Celina Pérez; Maria Teresa Colella; Arantza Roselló; Carolina Olaizola; Sylvia Magaldi Teresa Abate
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

Review 4.  Hospital epidemiology and infection control in acute-care settings.

Authors:  Emily R M Sydnor; Trish M Perl
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Cloning and characterization of a complex DNA fingerprinting probe for Candida parapsilosis.

Authors:  L Enger; S Joly; C Pujol; P Simonson; M Pfaller; D R Soll
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

6.  Candida albicans INT1-induced filamentation in Saccharomyces cerevisiae depends on Sla2p.

Authors:  C M Asleson; E S Bensen; C A Gale; A S Melms; C Kurischko; J Berman
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

7.  Enhanced extracellular production of aspartyl proteinase, a virulence factor, by Candida albicans isolates following growth in subinhibitory concentrations of fluconazole.

Authors:  T Wu; K Wright; S F Hurst; C J Morrison
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

8.  Identification and phylogenetic relationship of the most common pathogenic Candida species inferred from mitochondrial cytochrome b gene sequences.

Authors:  K Yokoyama; S K Biswas; M Miyaji; K Nishimura
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

9.  Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates.

Authors:  M A Pfaller; S R Lockhart; C Pujol; J A Swails-Wenger; S A Messer; M B Edmond; R N Jones; R P Wenzel; D R Soll
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  The Candida albicans KRE9 gene is required for cell wall beta-1, 6-glucan synthesis and is essential for growth on glucose.

Authors:  M Lussier; A M Sdicu; S Shahinian; H Bussey
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.